Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19

Christopher D. Richardson

doi:10.1016/S2213-2600(21)00366-0

Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19

Christopher D. Richardson

Medicine

Résultat de recherche: Comment/debate › examen par les pairs

4 Citations (Scopus)

Langue d'origine	English
Pages (de-à)	1207-1209
Nombre de pages	3
Journal	The Lancet Respiratory Medicine
Volume	9
Numéro de publication	11
DOI	https://doi.org/10.1016/S2213-2600(21)00366-0
Statut de publication	Published - nov. 2021

ASJC Scopus Subject Areas

Pulmonary and Respiratory Medicine

PubMed: MeSH publication types

Journal Article

ODD de l’ONU

Cette action contribue à la réalisation des objectifs de développement durable suivants

Accès au document

10.1016/S2213-2600(21)00366-0

Autres fichiers et liens

Citer

@article{be87b88317354fc09cb68443d6178c6c,

title = "Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19",

author = "Richardson, {Christopher D.}",

year = "2021",

month = nov,

doi = "10.1016/S2213-2600(21)00366-0",

language = "English",

volume = "9",

pages = "1207--1209",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Limited",

number = "11",

}

TY - JOUR

T1 - Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19

AU - Richardson, Christopher D.

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85118487930&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85118487930&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(21)00366-0

DO - 10.1016/S2213-2600(21)00366-0

M3 - Comment/debate

C2 - 34391548

AN - SCOPUS:85118487930

SN - 2213-2600

VL - 9

SP - 1207

EP - 1209

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 11

ER -